Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the.

Slides:



Advertisements
Similar presentations
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Advertisements

Robert C. Stanton, MD  American Journal of Kidney Diseases 
Chronic Kidney Disease in Diabetes
Volume 67, Pages S1-S7 (June 2005)
Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index  Suma Vupputuri, PhD, Caroline.
Uric Acid and Long-term Outcomes in CKD
Volume 67, Issue 6, Pages (June 2005)
CKD: Common, Harmful, and Treatable—World Kidney Day 2007
KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD  Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,
Peritoneal dialysis American Journal of Kidney Diseases
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
Section 2: AKI Definition
Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline  Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,
Metabolic Complications in Elderly Adults With CKD
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.
A Decade After the KDOQI CKD Guidelines
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.
World Kidney Day 2014: CKD and the Aging Population
Update on acute kidney injury after cardiac surgery
Cardiovascular Disease and CKD: Core Curriculum 2010
Recognition for Conservative Care in Kidney Failure
CKD and Poverty: A Growing Global Challenge
A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome
Anne M. Butler, PhD, Andrew F. Olshan, PhD, Abhijit V
Andrew Narva  American Journal of Kidney Diseases 
Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation–Kidney Early Evaluation Program (KEEP) 2012.
Shared Primacy of Sodium and Potassium on Cardiovascular Risk
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Volume 72, Issue 10, Pages (November 2007)
Daniel E. Weiner, MD, MS  American Journal of Kidney Diseases 
Meeting the challenges of the new K/DOQI guidelines
National Kidney Foundation  American Journal of Kidney Diseases 
Salt and Hypertension American Journal of Kidney Diseases
Guidelines for the Older Adult With CKD
Lifetime Incidence of CKD Stages 3-5 in the United States
Volume 75, Issue 10, Pages (May 2009)
Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS 
A Decade After the KDOQI CKD Guidelines: A Historical Perspective
David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD 
Julie A. Wright Nunes, MD, MPH, Kerri L
The Map Is Not the Territory—Mapping Out the Course and Cost of CKD
Cardiovascular Risk Assessment Among Potential Kidney Transplant Candidates: Approaches and Controversies  Krista L. Lentine, MD, MS, Frank P. Hurst,
American Journal of Kidney Diseases
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
CPR 1.2.: Evaluation of Anemia in CKD
Nephrology: As It Was Then, But Is Not Now
Beef Tea, Vitality, Creatinine, and the Estimated GFR
A Timely Evaluation of the Psychometric Properties of the KDQOL-36
American Journal of Kidney Diseases
Evidence and Outcomes in CKD
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Risk for Incident Renal Dialysis in a Managed Care Population
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD 
Removal of Dabigatran by Hemodialysis
Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm  David P. Calfee, MD, MS  American Journal of Kidney.
Volume 72, Issue 3, Pages (August 2007)
National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary  Adam T. Whaley-Connell, DO, MSPH, Joseph.
Introduction: The case for updating and context
The Use of Vaccines in Adult Patients With Renal Disease
Achieving Fairness in Access to Kidney Transplant: A Work in Progress
Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.
Conceptual model of the course of chronic kidney disease (CKD).
James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD 
Dialysis Research and N-of-1 Trials: Made for Each Other?
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Presentation transcript:

Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the Centers for Disease Control and Prevention  Andrew S. Levey, MD, Anton C. Schoolwerth, MD, MSHA, Nilka Ríos Burrows, MPH, MT, Desmond E. Williams, MD, PhD, Karma Rabon Stith, PhD, CHES, William McClellan, MD, MPH  American Journal of Kidney Diseases  Volume 53, Issue 3, Pages 522-535 (March 2009) DOI: 10.1053/j.ajkd.2008.11.019 Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Trends in treated kidney failure by race and age. Incidence counts and rates for kidney failure treated by dialysis and transplantation (A) by race, adjusted for age and sex, and (B) by age, adjusted for race and sex. Reproduced with permission from the 2007 Annual Data Report of the US Renal Data System.11 American Journal of Kidney Diseases 2009 53, 522-535DOI: (10.1053/j.ajkd.2008.11.019) Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Conceptual model of the public health approach for chronic kidney disease (CKD). Green circles, stages of CKD; blue circles, potential antecedents or consequences of CKD; thick arrows between circles, risk factors associated with the initiation and progression of disease that can be affected or detected by interventions; purple circles, outcomes of CKD. “Complications” refers to all complications of CKD and its treatment, including complications of decreased glomerular filtration rate (hypertension, anemia, malnutrition, and bone and mineral disease) and cardiovascular disease. Preventive strategies are shown below the target populations and risk factors to which they apply. Primary, secondary, and tertiary prevention refer to CKD. Modified and reprinted with permission.2 American Journal of Kidney Diseases 2009 53, 522-535DOI: (10.1053/j.ajkd.2008.11.019) Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions